Bottom line
FHCPX vs PRHSX: the short answer
FHCPX (Health Care Portfolio) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.
PRHSX is cheaper at 0.83% vs 1.66% — a difference of $83 a year per $10,000 invested.
Updated Nov 19, 2026
FHCPX vs PRHSX side by side
| FHCPX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.66% | 0.83% |
| Annual cost per $10k | $166 | $83 |
| 10-yr cost on $10k (prospectus) | $1,766 | $1,025 |
| Max front load | — | — |
| 12b-1 fee | 1% | — |
| 1-yr return | — | +17.7% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | +9.1% |
| Best quarter | +22.2% | +23.5% |
| Worst quarter | −15.0% | −15.8% |
| Net assets (fund) | $5.8B | $11.9B |
| Number of holdings | 152 | 279 |
| Portfolio turnover | 69% | 62% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of FHCPX's top 25 holdings also appear in PRHSX's top 25.
| Holding | FHCPX | PRHSX |
|---|---|---|
| ELI LILLY and CO | 8.03% | 14.28% |
| Danaher Corp | 6.89% | 1.43% |
| JOHNSON and JOHNSON | 4.91% | 6.63% |
| Thermo Fisher Scientific Inc | 4.33% | 2.52% |
| Unitedhealth Group Inc | 3.49% | 5.99% |
| Gilead Sciences Inc | 2.21% | 2.82% |
| Abbvie Inc | 2.03% | 5.10% |
| MERCK and CO INC | 1.60% | 4.01% |
| Cvs Health Corp | 1.29% | 0.94% |
| Natera Inc | 1.27% | 1.44% |
| Brightspring Health Services Inc | 1.23% | 0.82% |
| Moderna Inc | 1.18% | 0.83% |
Source: SEC Form N-PORT
FHCPX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between FHCPX and PRHSX?
FHCPX (Health Care Portfolio) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. PRHSX is cheaper at 0.83% vs 1.66% — a difference of $83 a year per $10,000 invested.
Which is cheaper, FHCPX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both FHCPX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.